Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV003301379 | SCV003996312 | uncertain significance | Cardiovascular phenotype | 2023-05-14 | criteria provided, single submitter | clinical testing | The p.H508R variant (also known as c.1523A>G), located in coding exon 10 of the SOS2 gene, results from an A to G substitution at nucleotide position 1523. The histidine at codon 508 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
| Labcorp Genetics |
RCV005061225 | SCV005713494 | likely benign | Noonan syndrome 9 | 2024-06-23 | criteria provided, single submitter | clinical testing |